Advertisement

Excited Delirium Syndrome

  • Vincent J. M. Di Maio
  • Theresa G. Di Maio
Chapter

Delirium involves an acute (minutes to hours), transient disturbance in consciousness and cognition. It is manifested by disorientation, disorganized and inconsistent thought processes, inability to distinguish reality from hallucinations, disturbances in speech, disorientation to time and place, and misidentification of individuals [1]. When the delirium involves combative and/or violent behavior, it is termed excited delirium (ED).

Keywords

Carotid Sinus Physical Restraint Natural Disease Pulseless Electrical Activity Peripheral Oxygen Saturation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. Washington, DC: American Psychiatric Association, 2000.Google Scholar
  2. 2.
    Di Maio T.G. and Di Maio V.J.M. Excited Delirium Syndrome. Boca Raton, FL: CRC Press Inc., 2006.Google Scholar
  3. 3.
    Bell L.V. On a Form of Disease resembling some advanced stages of mania and fever. Amer. J. Insanity 6:97–127, 1849.Google Scholar
  4. 4.
    Cancro R. The Introduction of Neuroleptics: A Psychiatric Revolution. Psychiatric Services 51(3), 2000.Google Scholar
  5. 5.
    Lieberman J.A., Golden R., Stroup S., and McEnvoy J. Drugs of the psychopharmacological revolution in clinical psychiatry. Psychiatric Services 51(10), 2000.Google Scholar
  6. 6.
    Di Maio V.J.M. and Di Maio, D. Forensic Pathology, 2nd ed. Boca Raton, FL: CRC Press Inc., 2001.Google Scholar
  7. 7.
    Stratton S.J., Rogers C., Brickett, K., and Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Amer. J. Emerg. Med. 19(3):187–191, 2001.CrossRefGoogle Scholar
  8. 8.
    Weiss S. and Baker J.P. The carotid sinus reflex in health and disease. Medicine 12:297–354, 1933.CrossRefGoogle Scholar
  9. 9.
    Thomas J.E. Hyperactive carotid sinus reflexes and carotid sinus syncope. Mayo Clinic. Proc. 44:127–139,1969.Google Scholar
  10. 10.
    Walter P.F., Crawley I.S., and Dorney E.R. Carotid sinus hyppersensitivity and syncope. Amer. J. Cardiology. 42: 396–403, 1978.CrossRefGoogle Scholar
  11. 11.
    Reay D.T., Howard J.D., Fligner C.L., and Ward, R.J. Effects of positional restraint on oxygen saturation and heart rate following exercise. Amer J. Forensic Med. Path. 9(1):16–18, 1988.CrossRefGoogle Scholar
  12. 12.
    O’Halloran R.L. and Lewman L.V. Restraint asphyxiation in excited delirium. Am. J. Forensic Med. Pathol. 14(4):289–295, 1993.PubMedCrossRefGoogle Scholar
  13. 13.
    Chan T.C., Vilke G.M., Neuman T., and Clausen L. Restraint positional asphyxia. Ann. Emerg. Med. 1997;30(5):578–586.PubMedCrossRefGoogle Scholar
  14. 14.
    Michalewicz B.A., Chan T.C., Vilke G.M., Levy S.S., Neuman T.S., and Kolkhorst F.W. Ventilatory and metabolic demands during aggressive physical restraint in healthy adults. J. Forensic Sci. 52(1):171–175, 2007.PubMedCrossRefGoogle Scholar
  15. 15.
    Guyton A.C. and Hall J.E. Medical physiology, 10th ed. Philadelphia: WB Saunders, 2000.Google Scholar
  16. 16.
    World Health Organization. Neuroscience of Psychoactive Substance Use and Dependence, 2004.Google Scholar
  17. 17.
    Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology, 8th ed. New York: Oxford University Press, 2003.Google Scholar
  18. 18.
    Katz A.M. Physiology of the heart. Philadelphia, PA: Lippincott Williams & Wilkins, 2001.Google Scholar
  19. 19.
    Insel PA. Seminars in medicine of the Beth Israel Hosp., Boston: Adrenergic receptors – evolving concepts and clinical implications (Review article). New Eng. J. Med. 334(9):580–585, 1996.PubMedCrossRefGoogle Scholar
  20. 20.
    Calzada B.C. and De Artinano A.A. Alpha-adrenoceptor subtypes. Pharm. Res. 44(3):195–208, 2001.CrossRefGoogle Scholar
  21. 21.
    Guimaraes S. and Moura D. Vascular adrenoceptors: an update. Pharm. Reviews. 53:319–356, 2001.Google Scholar
  22. 22.
    Heusch G., Baumgart D., Camici P., et al. [alpha]- Adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 101(6):689–694, 2000.PubMedGoogle Scholar
  23. 23.
    Lange R.A. and Hillis L.D. Cardiovascular complications of cocaine use. New Eng. J. Med. 345(5):351–358, 2001.PubMedCrossRefGoogle Scholar
  24. 24.
    Hajjar R.J. and MacRae C.A. Editorial”Adrenergic-receptor polymorphism and heart failure. New Eng. J. Med. 347(15):1196–1198, 2002.PubMedCrossRefGoogle Scholar
  25. 25.
    Small K.M., Wagoner L.E., Levin A.M., Kardia S.L.R., and Liggett S.B. Synergistic polymorphisms of B 1 and alpha 2c adrenergic receptors and the risk of congestive heart failure. New Eng. J. Med. 347(15):1135–1142, 2002.PubMedCrossRefGoogle Scholar
  26. 26.
    Dimsdale J.E., Hartley G.T., Guiney T., Ruskin J.N., and Greenblatt D. Post-exercise peril: Plasma catecholamines and exercise. JAMA 251:630–632, 1984.PubMedCrossRefGoogle Scholar
  27. 27.
    Young D.B., Srivastava T.N., Fitzovich D.E., Kivlighn S.D., and Hamaguchi M. Potassium and catecholamine concentrations in the immediate post exercise period. Am. J Med. Sci. 304:150–153, 1992.PubMedCrossRefGoogle Scholar
  28. 28.
    Rastergar A. and Soleimani M. Hypokalaemia and hyperkalaemia. Postgrad Med J. 77:759–764, 2001.PubMedCrossRefGoogle Scholar
  29. 29.
    Gennar F.J. Current concepts: Hypokalemia (review article). New Eng. J. Med. 339(7):451–458, 1998.CrossRefGoogle Scholar
  30. 30.
    Medbo J.I. and Sejersted O.M. Plasma potassium changes with high intensity exercise. J Physiol. 421:105–122, 1990.PubMedGoogle Scholar
  31. 31.
    Lindinger M.I. Potassium regulation during exercise and recovery in humans: implications for skeletal and cardiac muscle. J. Mol. Cell. Cardiol. 27(4):1011–1022, 1995.PubMedCrossRefGoogle Scholar
  32. 32.
    Paterson D.J., Rogers J., Powell T., and Brown H.F. Effect of catecholamines on the ventricular myocyte action potential in raised extracellular potassium. Acta Physiologica. Scand. 148:177–186, 1993.CrossRefGoogle Scholar
  33. 33.
    Leitch S.P. and Paterson D.J. Interactive effects of K+, acidosis, and catecholamines on isolated rabbit heart: implications for exercise. J. Appl. Physiol. 77(3):1164–1171, 1994.PubMedGoogle Scholar
  34. 34.
    Karch S.B., Green G.S., et al. Myocardial hypertrophy and coronary artery disease in male cocaine users. J. Forensic Sci. 40(4):591–595, 1995.PubMedGoogle Scholar
  35. 35.
    Wiener R.S., Lockhart J.T., and Schwartz R.G. Dilated cardiomyopathy and cocaine abuse: report of two cases. Amer. J. Med. 81:699–701, 1986.PubMedCrossRefGoogle Scholar
  36. 36.
    Karch S.B. Karch’s Pathology of Drug Abuse, 3rd. ed. Boca Raton, FL: CRC Press, 2002.Google Scholar
  37. 37.
    Silver M.D., Gotlieb A.L., and Schoen F.J. Cardiovascular Pathology. Philadelphia, PA: Churchill Livingstone, 2001.Google Scholar
  38. 38.
    Spitito P., Bellone P., et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. New Eng. J. Med. 342(24):1778–1785, 2000.CrossRefGoogle Scholar
  39. 39.
    Staley J.K., Hearn W.L., Ruttenber A.J., Wetli C.V., and Mash D.C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther. 271:1678–1685, 1994.PubMedGoogle Scholar
  40. 40.
    Mash D.C., Pablo J., Ouyang Q., Hearn W.L., and Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 81:292–300, 2002.PubMedCrossRefGoogle Scholar
  41. 41.
    Billman G.E. Cocaine: a review of the toxic actions on cardiac function. Crit Rev. Toxicol. 25:113, 1995.PubMedCrossRefGoogle Scholar
  42. 42.
    Fleckenstein A.E., Gibb J.W., Hanson G.R. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacol. 406(1):1–13, 2000.PubMedCrossRefGoogle Scholar
  43. 43.
    McCann U.D. and Ricaurte G.A. Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci. Biobehavioral Rev. 27(8):821–826, 2004.CrossRefGoogle Scholar
  44. 44.
    Singer K. and Lundberg W.B. Ventricular arrythmias associated with the ingestion of alcohol. Ann. Intern. Med. 77:247–248, 1972.PubMedGoogle Scholar
  45. 45.
    Ettinger P.O., Wu C.F., De La Cruz C. Jr., Weisse A.B., Ahmed S.S., and Regan T.J. Arrhythmias and the “Holiday Heart”: alcohol-associated cardiac rhythm disorders. Am. Heart J. 95(5):555–562, 1978.PubMedCrossRefGoogle Scholar
  46. 46.
    Witchel H.J., Hancox J.C., and Nutt D.J. Psychotropic drugs, cardiac arrhythmia, and sudden death. J. Clin. Psychopharmacol. 23(1):58–77, 2003.PubMedCrossRefGoogle Scholar
  47. 47.
    Roden D.M. Drug-induced prolongation of the QT interval] New Eng. J. Med. 350(10):1013–1022, 2004.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Vincent J. M. Di Maio
    • 1
  • Theresa G. Di Maio
    • 1
  1. 1.Chief Medical Examiner (retired)(San Antonio)Bexar County

Personalised recommendations